The novelty of our study is that the combination of ALT-803 plus BCG stimulated the production of key sera and urinary cytokines (e.g., IL-1α, IL-1β and RANTES) leading to the activation and proliferation of NK cells, which led to the significant reduction in tumor burden. The gene discussed is IL1B; the disease is neoplasm.